130993-58-7

Basic information

• Product Name: Cyclohexanol, 2-(1-pyrrolidinyl)-, methanesulfonate (ester), (1R,2R)-rel-
• CAS NO: 130993-58-7
• Molecular Formula: C11H21NO3S
• Molecular Weight: 247.359
• Mol File: 130993-58-7.mol
• Article Data: 6

Chemical Properties

• CAS DataBase Reference: Cyclohexanol, 2-(1-pyrrolidinyl)-, methanesulfonate (ester), (1R,2R)-rel-(CAS DataBase Reference)
• NIST Chemistry Reference: Cyclohexanol, 2-(1-pyrrolidinyl)-, methanesulfonate (ester), (1R,2R)-rel-(130993-58-7)
• EPA Substance Registry System: Cyclohexanol, 2-(1-pyrrolidinyl)-, methanesulfonate (ester), (1R,2R)-rel-(130993-58-7)

Safety Data

• Hazardous Substances Data: 130993-58-7(Hazardous Substances Data)

Upstream product

• 286-20-4 cyclohexane-1,2-epoxide 
• 69420-67-3 (+/-)-trans-[2-(pyrrolidinyl)]cyclohexanol 
• 124-63-0 methanesulfonyl chloride 

Downstream Products

• 67197-96-0 U 50488 hydrochloride 
• 67198-13-4 trans-3,4-dichloro-N-methyl-N-[2-(1-pyrrolidynyl)-cyclohexyl]benzeneacetamide 
• 130993-54-3 2-(3,4-Dichloro-phenyl)-N-(3-hydroxy-propyl)-N-((1S,2S)-2-pyrrolidin-1-yl-cyclohexyl)-acetamide 
• 130993-55-4 N-(3-Hydroxy-propyl)-2-phenyl-N-((1S,2S)-2-pyrrolidin-1-yl-cyclohexyl)-acetamide 
• 130993-56-5 trans-N-(2-hydroxyethyl)-N-<2'-(N-pyrrolidinyl)cyclohexyl>phenylacetamide 
• 130993-57-6 N-(2-Hydroxy-ethyl)-N-((1S,2S)-2-pyrrolidin-1-yl-cyclohexyl)-benzamide 
• 67198-34-9 trans-(+/-)-N-methyl-2-(pyrrolidin-1-yl)cyclohexanamine 

Relevant articles and documents

Optimisation of the Anti-Trypanosoma brucei Activity of the Opioid Agonist U50488

Screening of the Sigma-Aldrich Library of Pharmacologically Active Compounds (LOPAC) against cultured Trypanosoma brucei, the causative agent of African sleeping sickness, resulted in the identification of a number of compounds with selective antiproliferative activity over mammalian cells. These included (+)-(1R,2R)-U50488, a weak opioid agonist with an EC50 value of 59nM as determined in our T.brucei invitro assay reported previously. This paper describes the modification of key structural elements of U50488 to investigate structure-activity relationships (SAR) and to optimise the antiproliferative activity and pharmacokinetic properties of this compound.

AMINOCYCLOHEXYL ETHER COMPOUNDS AND USES THEREOF

Aminocyclohexyl ether compounds of formula (I), or a solvate or pharmaceutically acceptable salt thereof: are disclosed. In said formula, A, X and R, -R5 have the meanings given in the description. The compounds of the present invention may be inco

N-Methyl-N--1-phenylcyclopropanecarboxylic amides - analogs of U50488 with much reduced opiate affinity and loss of κ-selectivity

(+/-)-N-methyl-N--1-phenylcyclopropanecarboxylic amide (1) and its dichloro analog (2) were synthesized.Compounds 1 and 2 are related to the κ-selective opiate U-50488 in that the benzylic methylene moiety in U-50488 has been replaced by a cyclopropane ring.As compared to U-50488, a 600-fold reduction in kappa-affinity was observed with these 2 compounds; while the reduction in μ-affinity was less than 2-fold.Unlike U-50488, 1 and 2 also show measurable δ-binding.To explain the observed anomaly, the steric interaction between the N-methyl group and the cyclopropane ring and the tendency of the cyclopropane ring to conjugate with the neighboring phenyl group, both affecting the accessible conformations of the amide side chains of 1 and 2, are cosidered important factors.